DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+13.79%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.38B
AUM Growth
+$2.38B
(-6.9%)
Cap. Flow
-$217M
Cap. Flow
% of AUM
-9.13%
Top 10 Holdings %
Top 10 Hldgs %
36.37%
Holding
147
New
12
Increased
26
Reduced
28
Closed
38
Top Buys
Top Sells
| 1 |
BLUE
bluebird bio
BLUE
|
$41.3M |
| 2 |
NXTM
NxStage Medical Inc.
NXTM
|
$37.9M |
| 3 |
ELGX
Endologix Inc
ELGX
|
$28.8M |
| 4 |
Pacira BioSciences
PCRX
|
$25.5M |
| 5 |
GSK
GSK
|
$24.5M |
Sector Composition
| 1 | Healthcare | 70.92% |
| 2 | Financials | 4.5% |
| 3 | Technology | 0.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $253M | 10.26% | 11,684,801 +3,603,394 | +45% | +$78.1M |
|
|
NXTM
2
DELISTED
NxStage Medical Inc.
NXTM
| $101M | 4.08% | 4,589,000 -1,729,050 | -27% | -$37.9M |
|
|
DYAX
3
DELISTED
DYAX CORPORATION
DYAX
| $84.3M | 3.42% | 2,242,073 -615,700 | -22% | -$23.2M |
|
|
ADPT
4
DELISTED
Adeptus Health Inc.
ADPT
| $71.3M | 2.89% | 1,307,908 +762,580 | +140% | +$41.6M |
|
|
5
GSK
GSK
$79.9B
| $67.6M | 2.74% | 1,675,385 -607,337 | -27% | -$24.5M |
|
|
AET
6
DELISTED
Aetna Inc
AET
| $63.9M | 2.59% | 591,465 -44,574 | -7% | -$4.82M |
|
7
DaVita
DVA
$9.85B
| $57.3M | 2.32% | 822,000 +106,000 | +15% | +$7.39M |
|
8
Viatris
VTRS
$12.3B
| $57.1M | 2.31% | 1,056,000 -219,000 | -17% | -$11.8M |
|
9
Vanda Pharmaceuticals
VNDA
$279M
| $55.8M | 2.26% | 5,996,691 +1,212,534 | +25% | +$11.3M |
|
10
Teva Pharmaceuticals
TEVA
$21.1B
| $53.5M | 2.17% | 815,000 +200,000 | +33% | +$13.1M |
|
|
AVDL
11
Avadel Pharmaceuticals
AVDL
$1.43B
| $49.7M | 2.02% | 4,072,809 | – | – |
|
|
GBT
12
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $37.6M | 1.52% | 1,163,811 +273,191 | +31% | +$8.83M |
|
|
ARRY
13
DELISTED
Array Biopharma Inc
ARRY
| $36.8M | 1.49% | 8,729,361 -1,000,000 | -10% | -$4.22M |
|
|
PTLA
14
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $35.2M | 1.43% | 683,749 +353,912 | +107% | +$18.2M |
|
|
SAGE
15
DELISTED
Sage Therapeutics
SAGE
| $34.9M | 1.42% | 598,854 -50,210 | -8% | -$2.93M |
|
|
XNPT
16
DELISTED
XENOPORT, INC.
XNPT
| $34.5M | 1.4% | 6,287,374 +2,842,000 | +82% | +$15.6M |
|
|
AAC
17
DELISTED
AAC Holdings, Inc.
AAC
| $34M | 1.38% | 1,782,094 +180,718 | +11% | +$3.44M |
|
|
INFI
18
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $33.8M | 1.37% | 4,305,288 +394,567 | +10% | +$3.1M |
|
|
UAM
19
DELISTED
Universal American Corp
UAM
| $33.5M | 1.36% | 4,789,027 -141,760 | -3% | -$992K |
|
|
WBA
20
DELISTED
Walgreens Boots Alliance
WBA
| $32.9M | 1.33% | 386,457 -77,000 | -17% | -$6.56M |
|
21
eHealth
EHTH
$118M
| $32.6M | 1.32% | 3,264,588 | – | – |
|
|
TVTY
22
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $31.7M | 1.29% | 2,465,042 | – | – |
|
23
Charles River Laboratories
CRL
$8.04B
| $30.3M | 1.23% | 377,188 -204,000 | -35% | -$16.4M |
|
|
ALPN
24
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $28.9M | 1.17% | 3,732,412 | – | – |
|
25
McKesson
MCK
$85.4B
| $28.5M | 1.16% | 144,646 -41,000 | -22% | -$8.09M |
|